Memorial Sloan Kettering Cancer Center (Craig B. Thompson), 2018-09-13: MSK's own message to staff confirming Baselga's resignation was accepted and effective immediately, naming Lisa DeAngelis as acting physician-in-chief and asserting that MSK has 'robust programs' for managing outside relationships.
Questions about Dr. Baselga’s disclosures and relationships with outside organizations have caused concern from the community, our staff, and most importantly our patients and family members.
Staff email, paragraph 4
Memorial Sloan Kettering Cancer Center (Craig B. Thompson), 2018-09-13: MSK's own message to staff confirming Baselga's resignation was accepted and effective immediately, naming Lisa DeAngelis as acting physician-in-chief and asserting that MSK has 'robust programs' for managing outside relationships. ACCESS NOTE: DocumentCloud served the full text on first retrieval and then returned a Cloudflare block on every retry, so the excerpt was captured at first read and could not be re-verified at delivery; the same email is quoted in CHE-19 and CHE-20. Primary institutional statement, published via DocumentCloud by ProPublica. No funder or conflicts. This is MSK's contemporaneous position – it does not concede that the disclosure failures reflected a program failure, and says 'we will remain diligent'. Study type: other.
